Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era.

Rohit Maini,David B Wong,Daniel Addison,Elizabeth Chiang,Steven D Weisbord,Hani Jneid

Journal of the American Society of Nephrology : JASN（2018）

引用 44|浏览6

暂无评分

摘要

Over the last few decades, studies have consistently demonstrated an increased risk of ischemic heart disease, heart failure, and arrhythmias in patients with kidney disease (KD).[1][1] The presence of KD also confers significantly greater risk for poor outcomes in patients with cardiovascular

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要